Seeking Alpha

Life Science Investing

Life Science Investing
Send Message
ABOUT
Biotechnology professional with over 15 years of US and Global oncology/hematology experience: provided commercial assessment on numerous in-licensing opportunities, led the successful global launch of a targeted therapy in a major solid tumor and as a Global Commercial Lead, advanced numerous oncology Phase I/II compounds into Phase III registrational trials.
SNAPSHOT
  • Description: Full-time Investor. Trading frequency: Monthly
  • Interests: Stocks - long
COMPANY
Currently, there is no company profile for Life Science Investing.
Blog
Currently, there are no blog details for Life Science Investing.
BOOK
Currently, there are no book details for Life Science Investing.
LATEST STOCKTALK more »
$ARIA . Agree. Bought in $7s,$6s and at $5.89. Reminds me of the Tysabri news years ago....huge buying opportunity IMO. Oct 9, 2013